Catalyst Wire Dossier Catalyst Wire Dossier

semaglutide (oral tablet)

semaglutide · Novo Nordisk A/S
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for semaglutide (oral tablet), covering 2024-04-03 to 2024-04-03. Get the full timeline:

Most recent: Clinical Trial Update: Research Study to Compare Three Doses of Semaglutide Tablets Taken Once Daily in People With Type 2 Diabetes [Phase 3]

See pricing